• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tamir Biotechnology Inc


Ticker Delisted

Snapshot for Tamir Biotechnology Inc (ACEL)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for ACEL

No chart data available.
  • 1M
  • 1Y
Interactive ACEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACEL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) 0.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 217.36
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACEL

No data available

Company Profile & Key Executives for ACEL

Tamir Biotechnology, Inc. is a biopharmaceutical company that discovers and develops new drugs for the treatment of cancer, HIV and autoimmune diseases. The Company develops drugs from frog ribonucleases, enzymes which inhibit cell growth, degrade ribonucleic acids, and induce cell death by interrupting protein synthesis.

More Company Profile & Key Executives for ACEL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil